Development and Commercialization Plan Sample Clauses
The Development and Commercialization Plan clause outlines the requirements and expectations for how a product or technology will be developed and brought to market by the parties involved. Typically, this clause specifies the need for a detailed written plan, including timelines, milestones, and responsibilities, and may require regular updates or approvals from both parties. Its core practical function is to ensure that both parties are aligned on the strategy and progress for development and commercialization, reducing misunderstandings and helping to manage risk and accountability throughout the partnership.
Development and Commercialization Plan. The expected Commercialization to be conducted by Ruthigen pursuant to this Article IV shall be set out in the Development and Commercialization Plan attached hereto as Schedule 3. Ruthigen may, from time to time, modify the Development and Commercialization Plan in its discretion. For so long as Ruthigen and Oculus are members of the same Consolidated Group, Ruthigen shall give Oculus prompt notice of any material deviation from the Development and Commercialization Plan and any material redefinition of Commercialization goals and strategy.
Development and Commercialization Plan. During the Term, the Licensee shall use good faith, reasonable commercial efforts to develop, manufacture, commercialize and market the Licensed Patents through a diligent program designed to accomplish the commercial exploitation of the same and to make the technology covered by or embedded in the Licensed Patents available to the general public in accordance with the procedures and practices that are usual and customary for similar technologies and industries utilizing those resources that would be employed by the Licensee of a product or compound of similar market potential at a similar stage in its development or product life as the Licensed Patents taking into account, without limitation, issues of safety and efficacy, product profile, intellectual property situation, regulatory environment and other relevant scientific and commercial factors). The Parties acknowledge that the Licensee has provided to UABRF the Development and Commercialization Plan set forth on attached Exhibit B which sets forth its current development and commercialization objectives. The Parties further acknowledge and agree that the Development and Commercialization Plan is, and the development and commercialization milestones, each set forth on attached Exhibits B and C, are reasonable.
Development and Commercialization Plan. The JSC will prepare a Development and Commercialization Plan for each Collaboration Product which will be attached hereto as Exhibit 1.38.
Development and Commercialization Plan. The Parties acknowledge and agree that Ruthigen’s Development and Commercialization shall not include any activities related to dermatological uses or uses related to the Indications. Any references to the OOS Option, the Indications or any product or service outside the definition of Invasive in the Development and Commercialization Plan are hereby deleted.
Development and Commercialization Plan. During the Term, the Licensee shall use commercially reasonable efforts to develop, manufacture, commercialize and market a Licensed Product in accordance with the procedures and practices that are usual and customary for similar technologies and industries. The Parties acknowledge that the Licensee has provided to UABRF the Development and Commercialization Plan set forth on attached Exhibit B which sets forth its current development and commercialization objectives. The Parties further acknowledge and agree that the Development and Commercialization Plan is, and the development and commercialization milestones set forth therein are reasonable.
Development and Commercialization Plan. During the term of this Agreement, LEVPHARMA agrees to use commercially reasonable efforts to manufacture and market Licensed Technology and Licensed Products. Such efforts will include sublicensing, development of promotional literature, direct marketing mailings, and journal advertisements. LEVPHARMA shall keep SANQUIN informed of LEVPHARMA's annually updated Development and Commercialization Plan for Licensed Technology and Licensed Products, including LEVPHARMA's planned timing/timelines for launch dates. All dates and other information provided by LEVPHARMA to SANQUIN shall be Confidential Information.
Development and Commercialization Plan. Development and Commercialization Plan" shall mean LEVPHARMA'S plan for the further development and commercialization of the Licensed Technology and any potential Licensed Products in the Field, see Exhibit B hereto.
Development and Commercialization Plan. During the Term, the Licensee shall use good faith, reasonable commercial efforts to develop, manufacture, commercialize and market the Licensed Patents through a diligent program designed to accomplish the commercial exploitation of the same and to make the technology covered by or embedded in the Licensed Patents available to the general public in accordance with the procedures and practices that are usual and customary for similar technologies and industries. The Parties acknowledge that the Licensee has provided to UABRF the Development and Commercialization Plan set forth on attached Exhibit B which sets forth its current development and commercialization objectives. The Parties further acknowledge and agree that the Development and Commercialization Plan is, and the development and commercialization milestones set forth therein are, reasonable.
Development and Commercialization Plan. The Parties agree to a development and commercialization plan with respect to each Product, as follows:
3.2.1. MR3 will implement bench-scale, prototype and pilot studies and develop commercial Products and processing systems in collaboration with PUROLITE.
3.2.2. The testing results will be provided to PUROLITE along with MR3's specifications and recommendations regarding resin improvements and modification, and new Product synthesis. PUROLITE will synthesize the Products based on MR3's specifications and data and will incorporate all possible improvements based on the Parties' joint development recommendations.
3.2.3. Each developed Product will be marketed under a trademark to be jointly owned by PUROLITE and MR3.
3.2.4. PUROLITE will provide reasonable samples of its existing resins or its modifications to MR3 free of charge on an "As Needed" basis.
3.2.5. PUROLITE and MR3 will jointly patent the new and modified Products based on MR3's tests and piloting work, and the Parties will have joint ownership of all intellectual property in the Products.
3.2.6. The Product resins will be marketed under PUROLITE's marketing program and applied by MR3 in its metals removal markets. The pricing of all Products will be set by PUROLITE, whether sold directly by PUROLITE, by MR3, or by third parties. The pricing of all MR3 turn-key systems shall be set by MR3.
3.2.7. PUROLITE agrees to pay MR3 a percentage of its gross receipts from the sale of any and all Products to a third party, payable monthly (within 30 days after PUROLITE has been paid by a third party). The percentage is determined by the selling price and margin as agreed by the Parties after determining the standard cost and selling price.
3.2.8. MR3 will be granted the right to purchase any of the Products from PUROLITE at an agreed upon price level. All costs will have to be determined in consideration of the price.
3.2.9. PUROLITE agrees to refer to MR3 all contacts, requests, leads, and the like, received by PUROLITE for the purchase or application of turn-key extraction or remediation systems which appear to benefit from the use of the Products.
Development and Commercialization Plan. During the Term, the Licensee shall [***] to develop, manufacture, commercialize and market the Licensed Patents through a diligent program designed to accomplish the commercial exploitation of the technology in the Licensed Patents in accordance with the usual and customary practices for the pharmaceutical and cosmetics industry. The Parties acknowledge that the Licensee has developed a written disclosure setting forth its development and commercialization objectives (the “Plan”) as set forth in Exhibit “B” (“Exhibit B”). The Parties further acknowledge and agree that the Development and Commercialization Plan is intended to achieve [***] in Section 5.3 and to accomplish the commercialization of the Licensed Products. Accordingly, such Plan is a dynamic arrangement that sets forth prospective activities that may change over time in accordance with research results, market opportunities and business conditions. The Licensee shall consult with UABRF in the design and implementation of its Development and Commercialization Plan to ensure a clear understanding of its proposed activities. However, the Licensee shall have the sole responsibility and control over business objectives and activities.